Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.

Name: Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Author: Fan, Yangwei

Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway. — المؤلف: Fan, Yangwei — Cancer biology & therapy 20200706

المؤلف: Fan, Yangwei
النشر: Cancer biology & therapy 20200706
الوصف: 617-632 p.
الموضوعات: Adaptor Proteins, Signal Transducing؛ Adult؛ Aftercare؛ Aged؛ Animals؛ Antineoplastic Combined Chemotherapy Protocols؛ Breast؛ Cell Cycle Proteins